Neuland Laboratories Limited (BOM: 524558)

Market Cap	160.22B
Revenue (ttm)	16.35B
Net Income (ttm)	3.36B
Shares Out	12.83M
EPS (ttm)	261.94
PE Ratio	47.67
Forward PE	55.52
Dividend	14.00 (0.11%)
Ex-Dividend Date	Jul 12, 2024

Volume	2,376
Open	12,713
Previous Close	12,641
Day's Range	12,151 - 12,761
52-Week Range	3,424 - 13,248
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1984
• Employees: 1,643
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524558

Financial Performance

In 2023, Neuland Laboratories's revenue was 15.59 billion, an increase of 30.81% compared to the previous year's 11.91 billion. Earnings were 3.00 billion, an increase of 83.51%.